219 related articles for article (PubMed ID: 36685833)
21. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q
Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436
[TBL] [Abstract][Full Text] [Related]
22. Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma.
Zou J; Zhang K; Zhu J; Tu C; Guo J
J Int Med Res; 2024 Jan; 52(1):3000605231218559. PubMed ID: 38180878
[TBL] [Abstract][Full Text] [Related]
23. PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD.
Dong P; Du X; Yang T; Li D; Du Y; Wei Y; Sun J
Oncol Lett; 2023 Dec; 26(6):512. PubMed ID: 37920431
[TBL] [Abstract][Full Text] [Related]
24. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
[TBL] [Abstract][Full Text] [Related]
25. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach.
Liu S; Liu P; Fei X; Zhu C; Hou J; Wang X; Pan Y
Oncol Lett; 2023 Jul; 26(1):285. PubMed ID: 37274465
[TBL] [Abstract][Full Text] [Related]
26. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
[TBL] [Abstract][Full Text] [Related]
27. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
28. LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma.
Liu J; Wang M; Wang M; Wang F; Zhang B
Biochem Genet; 2024 Feb; 62(1):485-503. PubMed ID: 37382751
[TBL] [Abstract][Full Text] [Related]
29. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
[TBL] [Abstract][Full Text] [Related]
30. PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy.
Du X; Yi X; Zou X; Chen Y; Tai Y; Ren X; He X
BMC Cancer; 2023 Nov; 23(1):1102. PubMed ID: 37957639
[TBL] [Abstract][Full Text] [Related]
31. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis.
Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P
Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515
[TBL] [Abstract][Full Text] [Related]
32. The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma.
Yu X; Sun R; Yang X; He X; Guo H; Ou C
J Cancer; 2023; 14(12):2274-2288. PubMed ID: 37576396
[TBL] [Abstract][Full Text] [Related]
33. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R
BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response.
Jiang Y; Ye Y; Huang Y; Wu Y; Wang G; Gui Z; Zhang M; Zhang M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15069-15083. PubMed ID: 37620430
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of SMC Gene Family Prognostic Value and Immune Infiltration in Patients With Pancreatic Adenocarcinoma.
Nie H; Wu Y; Ou C; He X
Front Med (Lausanne); 2022; 9():832312. PubMed ID: 35372377
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatic Analysis of Prognostic Value of Pyroptosis-Related Genes and Its Effect on Immune Cell Infiltration in Pancreatic Adenocarcinoma.
Wang J; Zhang H; Shao P; Zhang X; Zhou B
Int J Gen Med; 2022; 15():2311-2319. PubMed ID: 35256857
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():758725. PubMed ID: 34804125
[No Abstract] [Full Text] [Related]
38. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R
Front Genet; 2021; 12():702102. PubMed ID: 34335699
[TBL] [Abstract][Full Text] [Related]
39. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.
Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G
BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375
[TBL] [Abstract][Full Text] [Related]
40. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
Zou X; Guo Y; Mo Z
Front Genet; 2022; 13():905988. PubMed ID: 36419829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]